Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
E192613-5mg | 5mg | In stock | $39.90 | |
E192613-25mg | 25mg | In stock | $135.90 | |
E192613-50mg | 50mg | In stock | $189.90 | |
E192613-100mg | 100mg | In stock | $269.90 | |
E192613-250mg | 250mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $469.90 |
Potent and selective FABP4 inhibitor
Synonyms | 300657-03-8|BMS-309403|2-((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1'-biphenyl]-3-yl)oxy)acetic acid|BMS 309403|BMS309403|FABP4 Inhibitor|[2'-(5-Ethyl-3,4-diphenyl-pyrazol-1-yl)-biphenyl-3-yloxy]acetic acid|((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl) |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocke |
Storage Temp | Protected from light,Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Product Description | Product description: BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells; |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 2-[3-[2-(5-ethyl-3,4-diphenylpyrazol-1-yl)phenyl]phenoxy]acetic acid |
---|---|
INCHI | InChI=1S/C31H26N2O3/c1-2-27-30(22-12-5-3-6-13-22)31(23-14-7-4-8-15-23)32-33(27)28-19-10-9-18-26(28)24-16-11-17-25(20-24)36-21-29(34)35/h3-20H,2,21H2,1H3,(H,34,35) |
InChi Key | SJRVJRYZAQYCEE-UHFFFAOYSA-N |
Canonical SMILES | CCC1=C(C(=NN1C2=CC=CC=C2C3=CC(=CC=C3)OCC(=O)O)C4=CC=CC=C4)C5=CC=CC=C5 |
Isomeric SMILES | CCC1=C(C(=NN1C2=CC=CC=C2C3=CC(=CC=C3)OCC(=O)O)C4=CC=CC=C4)C5=CC=CC=C5 |
PubChem CID | 16122583 |
Molecular Weight | 474.55 |
CAS Registry No. | 300657-03-8 |
---|---|
PubChem CID | 16122583 |
ChEMBL Ligand | CHEMBL247920 |
RCSB PDB Ligand | T4B |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
D2428238 | Certificate of Analysis | Apr 18, 2024 | E192613 |
D2428239 | Certificate of Analysis | Apr 18, 2024 | E192613 |
D2428240 | Certificate of Analysis | Apr 18, 2024 | E192613 |
B2313124 | Certificate of Analysis | Oct 31, 2022 | E192613 |
B2313127 | Certificate of Analysis | Oct 31, 2022 | E192613 |
B2313128 | Certificate of Analysis | Oct 31, 2022 | E192613 |
B2313130 | Certificate of Analysis | Oct 31, 2022 | E192613 |
B2313131 | Certificate of Analysis | Oct 31, 2022 | E192613 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 47.45, Max Conc. mM: 100 |
---|---|
Sensitivity | light sensitive |